Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Covalon Technologies Ltd V.COV

Alternate Symbol(s):  CVALF

Covalon Technologies Ltd. is a patient-driven medical device company. Through a portfolio of patented technologies and solutions for advanced wound care, infection prevention, and medical device coatings, the Company offers gentler and more compassionate options for patients to heal with less infections, less pain, and better outcomes. Its solutions are designed for patients and made for care providers. It leverages its patented medical technology platforms and expertise in two ways: by developing products that are sold under Covalon’s name and by developing and commercializing medical products for other medical companies under development and license contracts. It provides a range of specialized medical devices, medical dressings and advanced medical technology designed for infection prevention, complex wound closure and perioperative care. Its perioperative care solutions provide antimicrobial protection of pre-operative skin, through postoperative incision care to scar prophylaxis.


TSXV:COV - Post by User

Bullboard Posts
Post by zenvestingon Oct 29, 2014 10:20pm
107 Views
Post# 23074981

Dual antimicrobial products are best in class infection ctrl

Dual antimicrobial products are best in class infection ctrlChlorhexidine-sivler combination products provide superior protecion against both gram negative AND gram possitive bacteria. Here is a study from the American Journal of Infection Control from this February showing that the more expensive dual antimicrobial catheters are cost justified when considering all of the costs of dealing with extended hospital stays associatrd with catheter-related bloodstream infections (CRBSI):
AJIC

This is just one study on a dual antimicrobial catheter, but the point is that when you say "silver is the standard", you are looking in the rearview mirror. You point to other companies in the catheter care market; but you somehow fail to see how Carefusion's Chlorhexidine-only dressing is inferior....oh wait....didn't you say silver the standard?
Carefusion IV securement

The "standards" are also rapidly changing as President Obama just signed an Executive Order to effectively declare war on Healthcare Acquired Infections and antibiotic resistant bacteria, including provisions for preventative measures:
Executive Order

So actually, your obtuse arguments and self-contradicting statements tell me more about your objective in posting here than any of the loosely reference associations you use to attempt to discredit the market potential of Covalon's dual antimicrobial technology.

Your handle here on Stockhouse dedicate to bashing Covalon is also rather curious; but last time you posted here on June 14th, you immediately preceeded a 40% run in the sock price....so keep it up please!
Bullboard Posts